Prevalence and geographical distribution of UK congenital myasthenic syndrome patients referred to the oxford national specialist commissioning advisory group service

Prevalence and geographical distribution of UK congenital myasthenic syndrome patients referred to the oxford national specialist commissioning advisory group service

Detalhes bibliográficos
Main Authors:	Lashley, D, Burke, G, Palace, J, Beeson, D, Goldsworthy, C, Newsom-Davis, J
Formato:	Conference item
Publicado em:	2007

Registos relacionados

A nationwide service for the diagnosis and treatment of congenital myasthenic syndromes
Por: Burke, G, et al.
Publicado em: (2006)

CLINICAL FEATURES OF THE SLOW-CHANNEL CONGENITAL MYASTHENIC SYNDROME
Por: Lashley, D, et al.
Publicado em: (2009)

Congenital myasthenic syndromes and the formation of the neuromuscular junction.
Por: Beeson, D, et al.
Publicado em: (2008)

Congenital myasthenic syndromes and the formation of the neuromuscular junction
Por: Beeson, D, et al.
Publicado em: (2008)

The genetic diagnosis of congenital myasthenic syndromes (CMS)
Por: Man, S, et al.
Publicado em: (2005)

The congenital myasthenic syndromes.
Por: Palace, J, et al.
Publicado em: (2008)

Ephedrine treatment in congenital myasthenic syndrome due to mutations in DOK7.
Por: Lashley, D, et al.
Publicado em: (2010)

Congenital myasthenic syndromes.
Por: Beeson, D, et al.
Publicado em: (1997)

Congenital myasthenic syndromes: an update.
Por: Finlayson, S, et al.
Publicado em: (2013)

Congenital myasthenic syndromes and the neuromuscular junction.
Por: Cruz, P, et al.
Publicado em: (2014)

Therapeutic strategies for congenital myasthenic syndromes
Por: Lee, M, et al.
Publicado em: (2018)

Clinical and experimental observations in patients with congenital myasthenic syndromes.
Por: Vincent, A, et al.
Publicado em: (1993)

Clinical and experimental observations in patients with congenital myasthenic syndromes.
Por: Vincent, A, et al.
Publicado em: (1993)

The neuromuscular junction and wide heterogeneity of congenital myasthenic syndromes
Por: Rodríguez Cruz, P, et al.
Publicado em: (2018)

Chronic stridor as an early presentation of congenital myasthenic syndrome due to RAPSN mutation
Por: Mewasingh, L, et al.
Publicado em: (2006)

Splice-site mutations in the achr epsilon subunit gene associated with congenital myasthenic syndrome
Por: Croxen, R, et al.
Publicado em: (2000)

Mutations in dok-7 underlie a congenital myasthenic syndrome with a (sic)Limb girdle broken vertical bar pattern of muscle weakness.
Por: Beeson, D, et al.
Publicado em: (2006)

Novel mutation in the muscle acetylcholine receptor a-subunit underlies a fast channel congenital myasthenic syndrome
Por: Webster, R, et al.
Publicado em: (2002)

Synaptic dysfunction in congenital myasthenic syndromes.
Por: Beeson, D
Publicado em: (2012)

Congenital myasthenic syndromes: recent advances
Por: Beeson, D
Publicado em: (2016)

Clinical features of congenital myasthenic syndrome due to mutations in DPAGT1
Por: Finlayson, S, et al.
Publicado em: (2013)

Clinical features of congenital myasthenic syndrome due to mutations in DPAGT1.
Por: Finlayson, S, et al.
Publicado em: (2013)

DOK7 congenital myasthenic syndrome.
Por: Palace, J
Publicado em: (2012)

Congenital myasthenic syndromes and the formation of the neuromuscular junction
Por: Beeson, D
Publicado em: (2008)

Recessive inheritance and variable penetrance of slow-channel congenital myasthenic syndromes.
Por: Croxen, R, et al.
Publicado em: (2002)

Mutation in the AChR ion channel gate underlies a fast channel congenital myasthenic syndrome.
Por: Webster, R, et al.
Publicado em: (2004)

Impaired neurotransmission in a mouse model of the slow channel congenital myasthenic syndrome is improved by the sympathomimetic drug ephedrine
Por: Webster, R, et al.
Publicado em: (2011)

Arthrogryposis multiplex congenita associated with congenital myasthenic syndrome due to mutations in the acetylcholine receptor delta subunit
Por: Brownlow, S, et al.
Publicado em: (2000)

Slow channel congenital myasthenic syndrome responsive to a combination of fluoxetine and salbutamol.
Por: Finlayson, S, et al.
Publicado em: (2013)

"THE EYES HAVE IT": INITIAL GENETIC SCREENING IN SUSPECTED CONGENITAL MYASTHENIA
Por: Lashley, D, et al.
Publicado em: (2010)

Congenital myasthenic syndromes in childhood: diagnostic and management challenges.
Por: Kinali, M, et al.
Publicado em: (2008)

Structural abnormalities of the AChR caused by mutations underlying congenital myasthenic syndromes.
Por: Beeson, D, et al.
Publicado em: (2003)

Congenital myasthenia - Rapsyn deficiency: How rare?
Por: Burke, G, et al.
Publicado em: (2003)

Muscle magnetic resonance imaging in congenital myasthenic syndromes
Por: Finlayson, S, et al.
Publicado em: (2016)

THE CLINICAL PHENOTYPIC SPECTRUM OF GFPT1 ASSOCIATED CONGENITAL MYASTHENIC SYNDROME
Por: Chaouch, A, et al.
Publicado em: (2012)

Identification of DPAGT1 as a new gene in which mutations cause a congenital myasthenic syndrome.
Por: Belaya, K, et al.
Publicado em: (2012)

Congenital myasthenic syndromes: Epidemiology, clinical phenotyping and aids to diagnosis in the neuromuscular clinic
Por: Healy, E, et al.
Publicado em: (2014)

AN UNUSUAL CASE OF CONGENITAL MYASTHENIC SYNDROME: THE MECHANISM FOR TREATMENT RESPONSE
Por: Spillane, J, et al.
Publicado em: (2012)

Congenital myasthenic syndrome caused by mutations in DPAGT.
Por: Klein, A, et al.
Publicado em: (2015)

Congenital myasthenic syndromes: Report of 7 Chile
Por: Kleinsteuber, K, et al.
Publicado em: (2003)